Results 101 to 110 of about 5,191,497 (165)

Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman’s Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation [PDF]

open access: yes
Introduction: Multicentric Castleman’s disease (MCD) with cutaneous involvement has rarely been discussed in dermatologic literature, with few reports. Cutaneous lesions in MCD may induce deep scars, causing a significant impact in the daily life of the ...
Santo Raffaele Mercuri   +29 more
core   +1 more source

The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman's disease. [PDF]

open access: yesKorean J Intern Med, 2021
Min GJ   +16 more
europepmc   +1 more source

Multicentric plasma cell variant Castleman's disease mimicking intrapulmonary malignancy. [PDF]

open access: yes, 2002
Multicentric Castleman’s disease (CD) is an unusual B cell lymphoproliferative disorder in HIV infected individuals,1 and is caused by human herpesvirus 8.
Cartledge, J D   +3 more
core   +1 more source

Absence of gallium uptake in multicentric Castleman's disease of plasma cell type

open access: yesHaematologica, 2001
Multicentric Castleman's disease (MCD) of plasma cell type is a reactive lymphoproliferative disease. While 67Ga scanning is useful in the detection of malignant lymphomas, its role in reactive lymphadenopathy is unknown.
CS Chim, FP Choi, GC Ooi, YL Kwong
doaj  

Autoimmune hemolytic anemia in multicentric Castleman's disease

open access: yesHaematologica, 1996
We report on a patient affected by multicentric Castleman's disease who developed an acute immunohemolytic anemia due to warm antibody. The clinical course was characterized by refractoriness to the steroidal treatment and by a dramatic improvement of ...
NL Liberato   +4 more
doaj  

Home - About - Disclaimer - Privacy